drugset / Trial / NCT03194555

The Preventive Treatment of Migraine With Low-Dose Naltrexone and Acetaminophen Combination

NCT03194555 ↗

Phase 2 Completed 12 enrolled Allodynic Therapeutics, Inc
RandomizedParallel-groupDouble-blindTreatment

Summary

The Preventive Treatment of Migraine with Low-Dose Naltrexone and Acetaminophen Combination: A Small, Randomized, Double-Blind, and Placebo-Controlled Clinical Trial with an Open-Label Extension for None-Responders

Timeline

Start
2017-08-25
Primary completion
2018-07-26
Completion
2018-07-28

Outcome

Missed primary endpoint

registry analysis (superiority test); Low-Dose Naltrexone and Acetaminophen Combination vs Placebo; p = 0.4267 NCT03194555 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule — —
Subject Naltrexone Small molecule — —

Indications